Report a side effect Contact Us
  • Who We Are
    Who We Are
    EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
    • Overview
    • Vision, Mission & Values
    • Our History
    • Chairman Message
    • News and Media
      • Press Releases
      • Media Library
    • Sustainability & CSR
  • Manufacturing Facilities
    Manufacturing Facilities
    EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.


    • Overview
    • Factory 1
    • Factory 2
    • Factory 3
    • Eiaco Factory
    • Eipico Plastic Factory
    • Industry Expansion
  • Science & Medicine
    Science & Medicine
    EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
    • Products
    • Products (Alphabetical)
    • R&D and Quality
    • Global Accreditation
    • Regulatory Affairs
  • Global
    Global
    EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
    • Overview
    • Our Export History
    • Eipico Destination
  • Investor Relations
    Investor Relations
    • Investor Relations
    • Annual Reports
  • EIPICO 3
    EIPICO 3
    The First Modular Biological and Biosimilar Facility in Egypt
    • EIPICO 3 (Biologicals & Biosimilars)
EIPICO Signs Strategic Partnership Agreement with Al Dana Medical Company.  

9 September 2025

 
Qatar Doha witnessed, in the presence of Dr. Ahmed Kelani, Chairman and Managing Director of EIPICO Pharmaceuticals in Egypt, and Mr. Mohammed Yousef Al Manea, Chairman of AlDana Medical Company in Qatar.

The signing of a strategic partnership agreement between the two companies to market and distribute EIPICO's pharmaceutical products in Qatar.

Dr. Ahmed Kelani emphasized that this strategic partnership comes within the framework of EIPICO's efforts to expand its regional and international presence and that Qatar represents a promising market with an advanced regulatory environment and a growing healthcare sector. He added that Al Dana Medical Company can be a strategic partner in Qatar, given its extensive experience and strong relationships.

For his part, Mr. Mohammed Yousef Al Mana, Chairman of Al Dana Medical Company, emphasized that this agreement represents a milestone in Al Dana Medical's journey to strengthen its position in the pharmaceutical and healthcare distribution sector in Qatar, and through this partnership, it seeks to open broader horizons for joint cooperation.


To view the news, visit:

Souq Al Dawaa website

Al Raya Newspaper

Gulf Times Newspaper





WE ARE EIPICO

EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million, currently raised to EGP 1500 Million.

Quick Links

  • EIPICO 3
  • News
  • Products
  • Global accreditation
  • Global
  • Investor relations

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

eipico@eipico.com.eg

Back to top
Powered by EIPICO Team
     Visitors Count : 1609955